Evidence map›Paper›PMID 11684592›Full record

ArticleAmerican journal of public health2001

Junking science to promote tobacco.

D Yach, S A Bialous

Abstract readComment
In one paragraph

Article in American journal of public health, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Junk science, tobacco, and agendas.American journal of public health · 2002
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

D YachNoncommunicable Diseases and Mental Health, World Health Organization, Geneva, Switzerland. yachd@who.int
S A Bialous

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the tobacco industry's claims that it has changed its practices, the toll of tobacco-related disease and death continues to grow worldwide, and the industry continues to use a vast array of strategies to promote its products and increase profits. This commentary discusses the ways the tobacco industry has created controversy about risk assessment and about the scientific evidence of the health hazards of secondhand smoke. The authors recommend that policymakers be more vigilant and that they demand transparency about affiliations and linkages between allegedly independent scientists and tobacco companies. They also urge policymakers to be prepared for new and continuing challenges posed by the tobacco industry, because, despite the industry's claims, there is little evidence of fundamental change in its objectives.

Indexed as

Conflict of InterestEpidemiologic StudiesPublic PolicyFinancing, OrganizedHumansResearch Support as TopicRisk AssessmentTobacco IndustryTobacco Smoke PollutionUnited StatesTobacco Smoke Pollution

Identifiers

PMID11684592
PMCPMC1446867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.